|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | -5.74% | -4.98% | +10.45% | 46.06B | ||
| +3.13% | +5.34% | +402.93% | +605.08% | 38.91B | ||
| +2.14% | +2.95% | +10.83% | +65.45% | 35.57B | ||
| +4.43% | -1.51% | +6.73% | -9.17% | 33.13B | ||
| +1.23% | -2.05% | +0.56% | +30.76% | 26.42B | ||
| +0.29% | -2.75% | - | - | 16.61B | ||
| +14.71% | +12.62% | +38.50% | +146.99% | 15.08B | ||
| -6.32% | -4.86% | +4.36% | +8.22% | 14.08B | ||
| +1.82% | +0.19% | +1.45% | -30.74% | 12.81B | ||
| Average | +2.34% | -0.43% | +57.55% | +103.38% | 26.52B | |
| Weighted average by Cap. | +2.22% | -1.28% | +75.35% | +129.70% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















